Liraglutide treatment ( n = @ ) significantly ( p@ @ ) increased the insulin secretion rate ( % mean change -LSB- @ % CI -RSB- ; @ % -LSB- @ , @ -RSB- vs -@ % -LSB- -@ , @ -RSB- ) and pancreatic beta cell sensitivity to intravenous glucose ( @ % -LSB- @ , @ -RSB- vs -@ % ( -@ , @ -RSB- ) , and decreased insulin clearance rate ( -@ % -LSB- -@ , @ -RSB- vs @ -LSB- @ , @ -RSB- ) as compared with placebo ( n = @ ) .